Legislature(2011 - 2012)BELTZ 105 (TSBldg)
01/27/2012 01:30 PM Senate JUDICIARY
| Audio | Topic |
|---|---|
| Start | |
| SB89 | |
| SB135 | |
| SB140 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | SB 135 | TELECONFERENCED | |
| *+ | SB 140 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| = | SB 89 | ||
SB 140-CATHINONE BATH SALTS
2:28:46 PM
CHAIR FRENCH announced the consideration of SB 140.
2:29:02 PM
KEVIN MEYER, sponsor of SB 140, stated that SB 140 will classify
certain synthetic cathinones as a schedule IIA controlled
substance. This street drug is marketed as bath salts with names
that target kids, and it has become a problem in Anchorage.
The USDEA classified synthetic cathinones as a schedule I drug,
and the Municipality of Anchorage, the U.S. military and 33
states have banned its use. Because the drug is not illegal,
kids and parents may not know the harmful effects. He deferred
to the committee to determine the correct penalty, and stated
that his intent was to focus on the manufacturers and
distributers rather than the casual user.
2:33:07 PM
CHAIR FRENCH said that when he first heard about bath salts he
thought it was a compound that was sold in retail outlets, but
that's incorrect. Bath salts is just a name for the compound and
it's actually being marketed through head shops.
SENATOR MEYER said that's correct; bath salts are legal and not
regulated, just as synthetic cannabinoids were marketed as
incense.
CHAIR FRENCH observed that it isn't sold at a grocery store and
it's not like Sudafed, which can be used to make something else.
This is a special product that has a common sounding name.
SENATOR MEYER agreed and added that it might also be sold in
some convenience stores.
CHAIR FRENCH said he'd like to know how it compares to the drug
known as "Spice."
2:34:44 PM
DR. MICHAEL COOPER, Deputy State Epidemiologist, Division of
Public Health, Department of Health and Social Services (DHSS),
stated that synthetic cathinones known as bath salts are an
important public health problem. The affects from using bath
salts appear to be more significant than for the synthetic drug
"Spice."
Synthetic cathinones are the active compounds and the
prepackaged powders are usually made in China or India. They are
for sale online and in stores in Alaska and are usually
deceitfully labeled. To avoid regulation they are almost always
labeled "not for human consumption," even though their purpose
is for recreational abuse by snorting, smoking, intravenous
injection, or being rectally administered.
These synthetic cathinones are derived from the parent compound
cathinone, a schedule I substance under the U.S. Controlled
Substances Act and both are similar to amphetamines. They
increase the level of certain neurotransmitters in the brain and
create an adrenalin rush, a sense of euphoria, increased
arousal, and alertness. The desired affects are similar to those
found with amphetamines, cocaine and ecstasy, but there are also
a host of unpredictable and undesirable effects. These include
agitation, aggression, hallucinations, paranoia, and seizures.
There are widespread reports of crimes and bizarre behavior
attributed to abuse of these compounds. Patient high on bath
salts can be a real danger to themselves and others. The Journal
of Orthopedics described a life-threatening skin infection
thought to be related to bath salt injection, resulting in
amputation of the patient's arm and a radical mastectomy.
There is no quick way to detect synthetic cathinones in a
patient in Alaska at this time. These drugs do not show up on
routine drug tests. There's a lab in California that can be used
to screen patients for confirmation of these synthetic
cathinones in their urine. There is also no antidote and no
specific treatment.
These drugs are relatively new on the recreational drug scene.
They were created in the 1950s as a possible treatment for
chronic fatigue, but were found to have a high abuse and
addiction potential so they fell out of favor. They started
getting popular in Europe about six years ago and widespread use
started in the U.S. just a couple of years ago. The number of
calls to poison control centers nationwide increased from about
300 in 2010 to over 6,000 in 2011. Over 30 states have already
enacted legislation banning the sale and possession of compounds
containing certain synthetic cathinones. The Drug Enforcement
Agency used its emergency scheduling authority to make certain
synthetic cathinones temporarily controlled while formulating a
long-term policy. Most states have controlled one or more of the
most common synthetic cathinones, but they can easily be made a
little different and still have powerful affects. Washington is
one state that has enacted broader legislation and Pennsylvania
incorporated some amendments to address this problem.
The Alaska section of epidemiology published a bulletin in
October 2011 documenting a few case reports of bath salts abuse
in Alaska, and emergency room doctors have detailed encounters
with patients under the influence of these drugs. There have
reportedly been about 15 calls from Alaska to the poison control
centers, which is an indicator that they're around and being
abused.
Public health considers the abuse of these synthetic cathinones
to be a growing threat. They're widely available and may contain
different potent psychoactive compounds. They may create
different and dangerous side effects, and by all accounts they
are gaining in popularity. An increasingly younger cohort is
abusing these drugs, in part because they are widely available
and appealing.
2:42:40 PM
ORIN DYM, Forensic Laboratory Manager, State Crime Laboratory,
said he was available to answer questions.
CHAIR FRENCH asked if Alaska law enforcement officers had sent
any of this material to the lab for analysis.
MR. DYM answered yes; the most common is 3,4-
methylenedioxypyrovalerone (MVPV) followed by Methylone, both of
which are an ecstasy equivalent. The lab has received various
other compounds, primarily from Anchorage, Kenai and the MatSu
Valley. Samples have come in from the rest of Alaska as well.
CHAIR FRENCH asked if it's possible to tell if the compound was
bought online and mailed to Alaska or sold in Alaskan
establishments.
MR. DYM replied there was no way of knowing, but they are
available both ways, and typically sold in half gram quantities
for about $40.
2:44:47 PM
SENATOR COGHILL asked if there was an established protocol for
testing for these compounds.
MR. DYM replied the crime lab is already capable of identifying
them.
SENATOR COGHILL asked if it's a blood test.
MR. DYM explained that the lab does bulk drug identification,
but it does not perform toxicology and analysis of drugs in
blood. Those methods are still in the development stage.
CHAIR FRENCH summarized that the lab can identify the powder but
can't detect it in someone's blood.
MR. DYM said that's correct, but a lot of private toxicology
labs are working on a test protocol to make that determination.
2:46:02 PM
QUINLAN STEINER, Public Defender, Public Defender Agency,
expressed concern about the level of offense and asked if there
was any consideration given to dropping it to schedule III. That
would be similar to what was done last year with the synthetic
cannabinoids bill. He noted that schedule IIa offenses have some
of the most severe penalties available under the state criminal
code.
CHAIR FRENCH said the sponsor indicated an interest in that
inquiry, and the committee would be mindful about where it set
the penalties.
2:48:17 PM
KATE BURKHART, Executive Director, Advisory Board on Alcoholism
and Drug Abuse (ABADA), clarified that she was speaking only on
behalf of the board, and noted the formal letter of support for
SB 140 in the packets. Responding to an earlier comment from the
Chair about whether these substances were used for other
legitimate purposes, she said the board initially had that same
concern, but that is not the case. She said that to her
knowledge these substances have no legitimate medical or food-
based purpose. They are created to stimulate the user and are
deceptively marketed to circumvent regulations. With regard to
Mr. Steiner's comments about the appropriate level of offense,
she said the effect of synthetic cathinones on the user is at
least if not more serious than synthetic THC and cannabinoids.
They are the equivalent of methamphetamines and amphetamines,
which are schedule IIa substances. The penalty for possession of
a IIa substance is very severe, but if the intent is to focus on
those that manufacture and distribute the substance then the
higher penalty is appropriate. The effect on the user, who
reportedly is a younger cohort and often less sophisticated, is
very severe. Classifying these compounds as schedule IIa drugs
is an appropriate use of the Legislature's power to regulate to
protect the health and safety of Alaskans, she concluded.
2:51:42 PM
CHAIR FRENCH closed public testimony and announced he would hold
SB 140 in committee. He commented that this brings up all the
debates about drug sentencing and penalties. The point is to get
people to stop using drugs when they're home working and living
as free citizens. Putting them in prison for 24 months doesn't
solve that problem, and prisons are expensive. The sponsor is
sensitive to that, as is the committee.
| Document Name | Date/Time | Subjects |
|---|---|---|
| SB 140 Sponsor Statement v.B.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 140 |
| SB 140 Letter of Support MOA.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 140 |
| SB 140 Letter of Support ABADA AMHB.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 140 |
| SB 135 Sullivan, Susan - Letter of Support.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 135 |
| SB 135 Brown, Peggy - Letter of Support.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 135 |
| SB 135 Foster, Karen - Letter of Support.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 135 |
| SB 135 Haag, Nancy - Letter of Support.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 135 |
| SB 135 Kester, Victor - Letter of Support.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 135 |
| SB 135 Sponsor Statement.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 135 |
| SB 135 Sectional Analysis.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 135 |
| SB 140 Support Article ADN 01.24.11.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 140 |
| SB 140 Support Article ADN 11.15.11.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 140 |
| SB 140 Support Article Alaska Dispatch 11.07.11.pdf |
SJUD 1/27/2012 1:30:00 PM |
SB 140 |